APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL
Authors:
Open Access
- 6 March 2017
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 31 (10) , 2057-2064
Abstract
Oncogenic driver mutations are those that provide a proliferative or survival advantage to neoplastic cells, resulting in clonal selection. Although most cancer-causing mutations have been detected in the protein-coding regions of the cancer genome; driver mutations have recently also been discovered within noncoding genomic sequences. Thus, a current challenge is to gain precise understanding of how these unique genomic elements function in cancer pathogenesis, while clarifying mechanisms of gene regulation and identifying new targets for therapeutic intervention. Here we report a C-to-T single nucleotide transition that occurs as a somatic mutation in noncoding sequences 4 kb upstream of the transcriptional start site of the LMO1 oncogene in primary samples from patients with T-cell acute lymphoblastic leukaemia. This single nucleotide alteration conforms to an APOBEC-like cytidine deaminase mutational signature, and generates a new binding site for the MYB transcription factor, leading to the formation of an aberrant transcriptional enhancer complex that drives high levels of expression of the LMO1 oncogene. Since APOBEC-signature mutations are common in a broad spectrum of human cancers, we suggest that noncoding nucleotide transitions such as the one described here may activate potent oncogenic enhancers not only in T-lymphoid cells but in other cell lineages as well.Keywords
This publication has 42 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancersNature Genetics, 2013
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemiaLeukemia, 2013
- LIM-domain-only proteins in cancerNature Reviews Cancer, 2013
- Gene Expression Commons: An Open Platform for Absolute Gene Expression ProfilingPLOS ONE, 2012
- Absence of Biallelic TCRγ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2010
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- UniPROBE: an online database of protein binding microarray data on protein-DNA interactionsNucleic Acids Research, 2009
- Synergy between sequence and size in Large-scale genomicsNature Reviews Genetics, 2005